Endocyte, Inc. (NASDAQ:ECYT) Investor Alert: Lawsuit Alleges False and Misleading Statements
An investor, who purchased shares of Endocyte, Inc. (NASDAQ:ECYT), filed a lawsuit in the U.S. District Court for the Southern District of Indiana over alleged violations of Federal Securities Laws by Endocyte, Inc. in connection with certain allegedly false and misleading statements made between March 21, 2014 and May 2, 2014
View full press release